Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)-Reference-Cited by-同舟云学术

Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)

Published:2016-03 Issue: Volume:56 Page:77-84
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Valentin T.,Le Cesne A.,Ray-Coquard I.,Italiano A.,Decanter G.,Bompas E.,Isambert N.,Thariat J.,Linassier C.,Bertucci F.,Bay J.O.,Bellesoeur A.,Penel N.,Le Guellec S.,Filleron T.,Chevreau C.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Incidence and survival in sarcoma in the United States: a focus on musculoskeletal lesions;Ng;Anticancer Res,2013

2. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases;Ducatman;Cancer,1986

3. Malignant peripheral nerve sheath tumor: analysis of treatment outcome;Wong;Int J Radiat Oncol Biol Phys,1998

4. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution;Anghileri;Cancer,2006

5. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome;Zou;Ann Surg,2009

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soft tissue sarcomas associated with neurofibromatosis: treatment experience;Bone and soft tissue sarcomas, tumors of the skin;2024-09-12

2. Clinical outcomes of carbon ion radiotherapy for malignant peripheral nerve sheath tumors.;Advances in Radiation Oncology;2024-09

3. Whole-Body Positron Emission Tomography with 18F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1;Journal of Investigative Dermatology;2024-08

4. Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome;American Journal of Medical Genetics Part C: Seminars in Medical Genetics;2024-07-18

5. Malignant Peripheral Nerve Sheath Tumor, a Heterogeneous, Aggressive Cancer with Diverse Biomarkers and No Targeted Standard of Care: Review of the Literature and Ongoing Investigational Agents;Targeted Oncology;2024-07-02